343 related articles for article (PubMed ID: 27502068)
21. Which cut-off value of serum anti-Müllerian hormone level can predict poor ovarian reserve, poor ovarian response to stimulation and in vitro fertilization success? A prospective data analysis.
Ficicioglu C; Cenksoy PO; Yildirim G; Kaspar C
Gynecol Endocrinol; 2014 May; 30(5):372-6. PubMed ID: 24576292
[TBL] [Abstract][Full Text] [Related]
22. Outcomes of anti-Müllerian hormone-tailored ovarian stimulation protocols in in vitro fertilization/intracytoplasmic sperm injection cycles in women of advanced age.
Liao CC; Lee RK; Lin SY; Lin MH; Hwu YM
Taiwan J Obstet Gynecol; 2016 Apr; 55(2):239-43. PubMed ID: 27125408
[TBL] [Abstract][Full Text] [Related]
23. Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.
Arce JC; La Marca A; Mirner Klein B; Nyboe Andersen A; Fleming R
Fertil Steril; 2013 May; 99(6):1644-53. PubMed ID: 23394782
[TBL] [Abstract][Full Text] [Related]
24. Random anti-Müllerian hormone predicts ovarian response in women with high baseline follicle-stimulating hormone levels : anti-Müllerian hormone in poor responders in assisted reproductive treatment.
Celik H; Bıldırcın D; Güven D; Cetinkaya MB; Alper T; Batuoğlu AS
J Assist Reprod Genet; 2012 Aug; 29(8):797-802. PubMed ID: 22573035
[TBL] [Abstract][Full Text] [Related]
25. Anti-Müllerian hormone (AMH) is a strong predictor of live birth in women undergoing assisted reproductive technology.
Lukaszuk K; Liss J; Kunicki M; Jakiel G; Wasniewski T; Woclawek-Potocka I; Pastuszek E
Reprod Biol; 2014 Sep; 14(3):176-81. PubMed ID: 25152514
[TBL] [Abstract][Full Text] [Related]
26. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
[TBL] [Abstract][Full Text] [Related]
27. Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection.
Wunder DM; Guibourdenche J; Birkhäuser MH; Bersinger NA
Fertil Steril; 2008 Dec; 90(6):2203-10. PubMed ID: 18291376
[TBL] [Abstract][Full Text] [Related]
28. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
[TBL] [Abstract][Full Text] [Related]
29. Anti-Müllerian hormone serum values and ovarian reserve: can it predict a decrease in fertility after ovarian stimulation by ART cycles?
Patrelli TS; Gizzo S; Sianesi N; Levati L; Pezzuto A; Ferrari B; Bacchi Modena A
PLoS One; 2012; 7(9):e44571. PubMed ID: 22984527
[TBL] [Abstract][Full Text] [Related]
30. Anti-Müllerian hormone levels in salpingectomized compared with nonsalpingectomized women with tubal factor infertility and women with unexplained infertility.
Grynnerup AG; Lindhard A; Sørensen S
Acta Obstet Gynecol Scand; 2013 Nov; 92(11):1297-303. PubMed ID: 24032634
[TBL] [Abstract][Full Text] [Related]
31. What number of oocytes is appropriate for defining poor ovarian response?
Kim SK; Lee JR; Jee BC; Suh CS; Kim SH
Yonsei Med J; 2015 Mar; 56(2):482-9. PubMed ID: 25683999
[TBL] [Abstract][Full Text] [Related]
32. Antimüllerian hormone levels are strongly associated with live-birth rates after assisted reproduction.
Brodin T; Hadziosmanovic N; Berglund L; Olovsson M; Holte J
J Clin Endocrinol Metab; 2013 Mar; 98(3):1107-14. PubMed ID: 23408576
[TBL] [Abstract][Full Text] [Related]
33. The influence of AMH on IVF success.
Gomez R; Schorsch M; Hahn T; Henke A; Hoffmann I; Seufert R; Skala C
Arch Gynecol Obstet; 2016 Mar; 293(3):667-73. PubMed ID: 26449238
[TBL] [Abstract][Full Text] [Related]
34. Predictive value of anti-Mullerian hormone for pregnancy outcomes following assisted reproductive techniques (ART) in Southwest China.
Liu L; Sun XY; Yang H; Feng XJ; Lan YZ
Reprod Health; 2022 Dec; 19(1):224. PubMed ID: 36514055
[TBL] [Abstract][Full Text] [Related]
35. Predicting the total number of retrieved oocytes following double ovarian stimulation (DuoStim).
La Marca A; Donno V; Longo M; Greco P; Cucinelli F; Varricchio MT; Listorti I; Greco E
Hum Reprod; 2023 Sep; 38(9):1784-1788. PubMed ID: 37470235
[TBL] [Abstract][Full Text] [Related]
36. In vitro fertilization outcomes after ablation of endometriomas using plasma energy: A retrospective case-control study.
Motte I; Roman H; Clavier B; Jumeau F; Chanavaz-Lacheray I; Letailleur M; Darwish B; Rives N
Gynecol Obstet Fertil; 2016 Oct; 44(10):541-547. PubMed ID: 27665252
[TBL] [Abstract][Full Text] [Related]
37. Predictive factors for ovarian response in a corifollitropin alfa/GnRH antagonist protocol for controlled ovarian stimulation in IVF/ICSI cycles.
Oehninger S; Nelson SM; Verweij P; Stegmann BJ
Reprod Biol Endocrinol; 2015 Oct; 13():117. PubMed ID: 26520396
[TBL] [Abstract][Full Text] [Related]
38. Anti-Müllerian hormone dynamics during GNRH-antagonist short protocol for IVF/ICSI in women with varying ovarian reserve levels.
Melado Vidales L; Fernández-Nistal A; Martínez Fernández V; Verdú Merino V; Bruna Catalán I; Bajo Arenas JM
Minerva Ginecol; 2017 Apr; 69(2):128-134. PubMed ID: 27310675
[TBL] [Abstract][Full Text] [Related]
39. Are age and anti-Müllerian hormone good predictors of ovarian reserve and response in women undergoing IVF?
Scheffer JAB; Scheffer B; Scheffer R; Florencio F; Grynberg M; Lozano DM
JBRA Assist Reprod; 2018 Sep; 22(3):215-220. PubMed ID: 29949322
[TBL] [Abstract][Full Text] [Related]
40. Gonadotrophin stimulation for in vitro fertilization significantly alters the hormone milieu in follicular fluid: a comparative study between natural cycle IVF and conventional IVF.
von Wolff M; Kollmann Z; Flück CE; Stute P; Marti U; Weiss B; Bersinger NA
Hum Reprod; 2014 May; 29(5):1049-57. PubMed ID: 24608520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
